Christopher Haqq, MD, PhD About the Phase 2 AMPLIFY-7p Study Trial Name: First in Human Phase 1/2 Trial of ELI-002 7P Immunotherapy as Treatment for Subjects...
May 23, 2023 at a glance In a small study, a personalized mRNA vaccine against pancreatic cancer elicited a strong anti-tumor immune response in half of...
Recent Comments